SBWire

Manufacturing Execution Systems (MES) are integrated software application aimed to provide manufacturing industries with the means to schedule and plan, direct and operate, and track and analyze their operations. Presently, manufacturing industries are experiencing increasing overhead and material costs. In addition, intense economic conditions are compelling manufacturers to surge production in a cost effective way. This in turn is leading to rising need for implementation of industrial control systems aimed to optimize processes and provide better visibility of the shop floor. Need for quicker turnarounds and efficient utilization of resources or inventories is further driving the need for automation in industries. MES solutions offers real-time information of the shop floor, allowing end user industries to quickly response to any challenge that could negatively impact efficiency, productivity and quality. In addition, MES solutions offer uninterrupted visibility into production operations, gaining an overall view of the shop floor. Demand for industrial automation, better visibility of the shop floor and need for real-time control and adjustments to operations is driving the demand for manufacturing execution system (MES).

Virus filtration is an important procedure in the pharmaceutical industry. It ensures the purity and steady consumption of valuable products, besides optimizing the economic process and preventing loss. Virus filtration feed streams generally exhibit high purity and heavy product concentrations. Retrovirus and parvovirus filtration membranes are two ultrafiltration membranes tested (and their performances compared) using realistic model feed streams consisting of minute virus of mice (recommended from FDA).

This report provides in-depth region wise and country wise analysis of the human vaccines market. Stakeholders of this report include manufacturers of human vaccines products, raw material suppliers, vaccine processing companies, and new players planning to enter the market.

In the moderately fragmented global market for menopausal hot flashes, the top eight companies accounted for a collective share of more than 50% in 2014, states TMR in a recent report. The top two vendors, Pfizer, Inc. and Novartis AG held a dominant share of nearly 30% of this, commanding a strong hold on the overall development prospects of the market.

Medical nonwoven disposables are important products in the global healthcare industry as they provide hygiene benefits over the woven fabrics. Woven fabrics used in hospitals, clinics and physician offices are vulnerable to hospital acquired infections (HAIs) and other infections such as AIDs and hepatitis. Medical nonwoven disposables prevent transmission of these infections to some extent since they are soon disposed of. Therefore, the increasing awareness about these infections and efforts to control these infections are driving the global market for medical nonwoven disposables market.

Aesthetic services aim toward causing a significant cosmetic change or enhancement, using advanced technologies and providing medically based procedures. Aesthetic services also focus on treating conditions like scars, acne, psoriasis, warts, moles, hair disorders, wrinkles, skin discoloration and improve cosmetic appearance and psychological well-being. Most commonly used aesthetic services are laser treatment (laser hair reduction, tattoo reversal, scar reversal, pigmented spots), and Botox which involves injecting of a mild neurotoxin that inhibits brain to send signals to affected skin areas thus reducing wrinkles.

The North America facial injectables market is quite monopolistic in nature with one player dominating the overall market dynamics. As of 2016, Allergan Plc., held a share 62.0% in the regional market. The company dominance is a result of the strong brand value of its drugs like Botox & Juvederm. Presently, Botox is leading the market and is expected to retain its stance all throughout 2024.

One of the key factors driving the global cryptococcosis market is the increasing incidence of cryptococcosis infections across the world. The number of patients suffering from cryptococcosis has been found to be on the rise at a faster rate than previously thought. The patients suffering from the fungal infection are found to be in high numbers among HIV positive patients.

North America leads the histone deacetylase inhibitors market with rapid acceptance of these products in this region. Globally, this market would be growing at a very rapid pace owing to a tremendous potential of this class of drugs in oncology therapy. Rising incidence of oncology and aging population would be the driving factors for this market.

Healthcare Associated Infections (HAI) are a major cause of mortality and morbidity on a worldwide scale. Each year HAIs lead to thousands of deaths. A majority of HAIs include conditions such as urinary tract infections, surgical site infections, bloodstream infections, gastroenteritis, and pneumonia. The overall HAI treatment market can be classified on the basis of devices and pharmaceuticals used for HAI treatment. The major pharmaceuticals used in HAI treatment are viral pharmaceuticals, bacterial pharmaceuticals, and fungal pharmaceuticals. The major drug classes used in the pharmaceuticals segment are B-Lactam Antibiotics, cephalosporins, quinolones, glycopeptides, lincosamides, polypeptides, carbapenems, lipopeptides, penicillins, macrolides, tuberculosis, etracyclines, sulfonamides, and other such formulations. The medical devices segment can be further categorized into catheters and ventilation devices and in-line sterile IV filtration.

The increasing prevalence of hemophilia is by far the leading factor driving the global hemophilia therapeutics market. The U.S. Centers for Disease Control and Prevention (CDC) states that hemophilia occurs in about one in 5,000 live births every year. The increasing focus on prophylactic treatment will be a shot in the arm for the market in the forthcoming years. The approach used in prophylactic treatment prevents spontaneous bleeding, improves the quality of life in terms of physical activities, and maintains the level of clotting.

HPV vaccines market is the most potential market as the annual worldwide incidences for cervical cancer is almost 0.5 million and for cancers of vulva and vagina its 40,000. In addition, to this annual incidence for high-grade cervical intraepithelial neoplasia (CIN) the precancerous condition of cervical cancer is almost 0.5 million globally. Thus, according to International Agency for Research and Cancer predicts the rate of HPV related cancer cases to rise 40% in near future. North America and Europe are major markets as the governments from major countries of these regions have publicly funded HPV vaccination.

For over a century, passengers from all walks of life have either started or ended their trip from New York's Grand Central Terminal. And it seems that some ghost riders are still making Grand Central Terminal their favorite stop according to the Ghost Doctors (aka Dr. Pete and Dr. Stew) noted paranormal investigators and licensed NYC tour guides.

Market.Biz Leading Research Firm has added latest report on "Global Gas-to-liquid (GTL) Market by Manufacturers, Regions, Type and Application, Forecast to 2022".

The global real-time location systems (RTLS) market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium insights, technology trends and forecast to 2022. It also focuses on the key drivers and opportunities in this market.

Magline, the global leader in the material handling industry, will be exhibiting several innovative products at ProMat 2017, the largest expo for the manufacturing and supply chain industries from April 3-6, 2016 in Chicago, IL. Magline will be at booth #S5219.

EGFR is the primary receptor recognized in a group of receptors and is a cell surface protein that binds to epidermal growth factor.EGFR is a cell membrane growth factor receptor characterized bytyrosine kinase receptor which plays very important role in the control of key cellular transduction pathways in both normal and cancerous cells.EGFR is the first molecular target against which monoclonal antibodies (mAb) have been developed in cancer therapy.

Synchrono, a leader in modern demand-driven manufacturing software, released its 2017 Top Ten Trends in Modern Demand-Driven Manufacturing. The list is based on interactions with hundreds of manufacturers and industry experts addressing challenges, innovation, and technologies associated with manufacturing digitization, visibility, and synchronization.

Topper Industrial will be exhibiting at ProMat 2017, the largest expo for the manufacturing and supply chain industries from April 3-6, 2016 in Chicago's McCormick Place at booth #S3814.

According to the new market research report, "Active Pharmaceutical Ingredient (API) Market, by Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biological), Drug Type (Generics, Branded), Classification (HPAPI, Others), Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, CNS, Oncology, Musculoskeletal Diseases, NSAIDs, Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022", published by Scalar Market Research, the global active pharmaceutical ingredient (API) market is expected to grow at a steady CAGR of 6.4% and reach USD 224.63 billion by the year 2022.

Growing prevalence of various cancers such as breast, lung, prostate and blood cancer accentuates the growth of histone methyltransferase market globally as they are widely utilized as a diagnostic option for the treatment of cancer. Moreover, increasing research and development activities for cancer drug development also accentuates the global market; as histone methyltransferase is utilized as a biomarker for the above mentioned studies. However, high cost and technological complexities associated with histone methyltransferase might hinder the demand globally.

According to the new market research report, "In-Vitro Diagnostics (IVD) Market, by Products (Instruments & Systems and Reagents & Consumables Segments), Applications (Immunochemistry, Clinical Chemistry, Hematology, Infectious Disease, Microbiology, Genetic Testing, and Histology & Cytology) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2021", published by Scalar Market Research, the in-vitro diagnostics market is expected to grow at a steady CAGR of 5.2% and become worth USD 77.38 billion by 2021. In 2016, the in-vitro diagnostics market is estimated to be worth USD 60.07 billion.

The nanosatellite and microsatellite market report provides analysis for the period 2014–2024, wherein the period from 2016 to 2024 is the forecast and 2015 is the base year. The report covers all the major trends and technologies playing a key role in the nanosatellite and microsatellite market's growth over the forecast period. It also highlights the drivers, restraints, and opportunities expected to influence the market's growth during the said period in terms of revenue (in US$ Mn), across the geographies including North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America region comprises of the U.S. and Canada, while the Europe region covers the U.K., Germany, France, Spain, Italy, and rest of Europe. Furthermore, the Asia Pacific region is divided into Japan, China, India, Indonesia, and rest of Asia Pacific. Latin America is further categorized into Brazil and rest of Latin America.

Real Estate Investors Association New York Community (REIA NYC) has released a mobile app designed to assist real estate investors and agents with investment goals. The app provides insights, continuing education and tools to assist real estate investors and agents in their real estate businesses.

Genetic engineering is the science for cloning or manipulating DNAs or genes to create new characteristic in organism or produce protein or hormone. Genetic engineering is mostly used for generating recombinant DNA and is done by inserting desired trait gene or by deletion or mutating gene in cell or virus known as vector. Genetically engineered plants, animals or microbes are called as genetically modified organisms.